How do you pay?
Which strength?
How many tablets?

How to pay the least

From

$4 for 30 tablets

Generic lisinopril and hydrochlorothiazide at Walmart. Pick the strength on your label for its own price.

What to do

  1. Ask your prescriber to send the prescription to your nearest Walmart. Or ask the store’s pharmacy to transfer it from your pharmacy.Find the nearest store 
  2. Ask for generic lisinopril and hydrochlorothiazide.See Walmart’s price list 

Other ways

Rather have it mailed? From $8 a month from Rx Outreach, by mail. Make a free account, then have your prescription sent there.

Open Rx Outreach 

A regular generic has the same active ingredient as Zestoretic, and the FDA requires it to work the same way.

See every pharmacy’s price

Compare every option

Brand name

Zestoretic, the original

Cash priceAsk the pharmacyUsually the highest price

We didn’t find a savings card or cash price from Zestoretic’s maker. Ask the pharmacy for Zestoretic’s cash price. With insurance, ask what your plan charges.

Authorized generic

There isn’t one.

Not soldThere isn’t one

Regular generic

Same active ingredient as Zestoretic. Fillers and dyes can differ.

From$4for 30 tablets at Walmart
Where to buy it and who makes it

Where to buy it

Pharmacies’ own cash prices for generic lisinopril and hydrochlorothiazide, lowest first.

Pick up in storeDelivered

From each pharmacy’s own site, read November 17, 2026. Confirm the price before you fill.

About these prices

Prices change, can differ by store and state, and may depend on the strength and how many you take. With insurance, ask what your plan charges; it can be less.

Who makes it

5 companies sell a generic of Zestoretic that the FDA rates a substitute. A pharmacy fills whichever one it stocks. To get a certain maker, ask for it by name; most pharmacies can order it in a day or two.

  • Actavis PharmaAll 3 strengths

    Has dyes: FD&C Red No. 40, FD&C Blue No. 2--aluminum lake · Made by Watson Laboratories

    How it looks, what’s in it, NDCs

    10 mg / 12.5 mg Pink, round, 8 mm, marked “WATSON / 860”

    PackageNDC
    Bottle of 1000591-0860-01
    Bottle of 5000591-0860-05

    20 mg / 12.5 mg Light blue, round, 10 mm, marked “WATSON / 861”

    PackageNDC
    Bottle of 1000591-0861-01
    Bottle of 5000591-0861-05

    20 mg / 25 mg Pink, round, 10 mm, marked “WATSON / 862”

    PackageNDC
    Bottle of 1000591-0862-01
    Bottle of 5000591-0862-05

    Inactive ingredients: silicon dioxide, dibasic calcium phosphate dihydrate, FD&C Red No. 40, magnesium stearate, mannitol, starch, corn, FD&C Blue No. 2--aluminum lake

    FDA label

  • CiplaAll 3 strengths

    Made by Invagen Pharmaceuticals

    How it looks, what’s in it, NDCs

    10 mg / 12.5 mg Peach, round, 6 mm, marked “IG / 446”

    PackageNDC
    Bottle of 9069097-968-05
    Bottle of 10069097-968-07
    Bottle of 50069097-968-12
    Bottle of 100069097-968-15

    20 mg / 12.5 mg White to off-white, round, 8 mm, marked “IG / 447”

    PackageNDC
    Bottle of 9069097-969-05
    Bottle of 10069097-969-07
    Bottle of 50069097-969-12
    Bottle of 100069097-969-15

    20 mg / 25 mg Peach, round, 8 mm, marked “IG / 448”

    PackageNDC
    Bottle of 9069097-971-05
    Bottle of 10069097-971-07
    Bottle of 50069097-971-12
    Bottle of 100069097-971-15

    Inactive ingredients: anhydrous dibasic calcium phosphate, mannitol, starch, corn, magnesium stearate, ferric oxide yellow, ferric oxide red

    FDA label

  • Exelan PharmaceuticalsAll 3 strengths

    Made by Invagen Pharmaceuticals

    How it looks, what’s in it, NDCs

    10 mg / 12.5 mg Pink, round, 6 mm, marked “IG / 446”

    PackageNDC
    Bottle of 9076282-446-90
    Bottle of 10076282-446-01
    Bottle of 50076282-446-05
    Bottle of 100076282-446-10

    20 mg / 12.5 mg White to off-white, round, 8 mm, marked “IG / 447”

    PackageNDC
    Bottle of 9076282-447-90
    Bottle of 10076282-447-01
    Bottle of 50076282-447-05
    Bottle of 100076282-447-10

    20 mg / 25 mg Pink, round, 8 mm, marked “IG / 448”

    PackageNDC
    Bottle of 9076282-448-90
    Bottle of 10076282-448-01
    Bottle of 50076282-448-05
    Bottle of 100076282-448-10

    Inactive ingredients: anhydrous dibasic calcium phosphate, mannitol, starch, corn, magnesium stearate, ferric oxide yellow, ferric oxide red

    FDA label

  • Lupin PharmaceuticalsAll 3 strengths

    Has a dye: FD&C Blue No. 2

    How it looks, what’s in it, NDCs

    12.5 mg / 10 mg Blue, hexagon (6 sided), 7 mm, marked “LL / B01”

    PackageNDC
    Bottle of 10068180-518-01
    Bottle of 50068180-518-02
    Pouch of 500068180-518-30

    12.5 mg / 20 mg Yellow, round, 8 mm, marked “LL / B02”

    PackageNDC
    Bottle of 10068180-519-01
    Bottle of 50068180-519-02
    Pouch of 500068180-519-30

    25 mg / 20 mg Orange, round, 8 mm, marked “LL / B03”

    PackageNDC
    Bottle of 10068180-520-01
    Bottle of 50068180-520-02
    Pouch of 500068180-520-30

    Inactive ingredients: anhydrous dibasic calcium phosphate, FD&C Blue No. 2, mannitol, starch, corn, magnesium stearate, aluminum oxide, ferric oxide yellow, ferric oxide red

    FDA label

  • Solco HealthcareAll 3 strengths

    Made by Prinston Pharmaceutical

    How it looks, what’s in it, NDCs

    10 mg / 12.5 mg White to off-white, round, 6 mm, marked “H150”

    PackageNDC
    Bottle of 10043547-420-10
    Bottle of 50043547-420-50
    Bottle of 100043547-420-11

    20 mg / 12.5 mg Yellow, round, 8 mm, marked “H151”

    PackageNDC
    Bottle of 10043547-421-10
    Bottle of 50043547-421-50
    Bottle of 100043547-421-11

    20 mg / 25 mg Pink mottled, round, 8 mm, marked “H152”

    PackageNDC
    Bottle of 10043547-422-10
    Bottle of 50043547-422-50
    Bottle of 100043547-422-11

    Inactive ingredients: dibasic calcium phosphate dihydrate, magnesium stearate, mannitol, starch, corn, ferric oxide yellow, ferric oxide red

    FDA label

Who sells it: FDA and Medicaid records, updated weekly. Each maker’s page, card and program is from its own site.

What to say at the pharmacy

“Before you fill my Zestoretic, can you tell me what I’d pay for the brand and for a generic?”

Paying cash? Ask for each one’s cash price. With insurance, ask what your plan charges for each.

What it’s used for

What the FDA label says

ZESTORETIC is indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including lisinopril and hydrochlorothiazide.

Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will require more than 1 drug to achieve blood pressure goals. For specific advice on goals and management, see published guidelines, such as those of the National High Blood Pressure Education Program’s Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC).

Numerous antihypertensive drugs, from a variety of pharmacologic classes and with different mechanisms of action, have been shown in randomized controlled trials to reduce cardiovascular morbidity and mortality, and it can be concluded that it is blood pressure reduction, and not some other pharmacologic property of the drugs, that is largely responsible for those benefits. The largest and most consistent cardiovascular outcome benefit has been a reduction in the risk of stroke, but reductions in myocardial infarction and cardiovascular mortality also have been seen regularly.

Elevated systolic or diastolic pressure causes increased cardiovascular risk, and the absolute risk increase per mmHg is greater at higher blood pressures, so that even modest reductions of severe hypertension can provide substantial benefit. Relative risk reduction from blood pressure reduction is similar across populations with varying absolute risk, so the absolute benefit is greater in patients who are at higher risk independent of their hypertension (for example, patients with diabetes or hyperlipidemia), and such patients would be expected to benefit from more aggressive treatment to a lower blood pressure goal.

Some antihypertensive drugs have smaller blood pressure effects (as monotherapy) in black patients, and many antihypertensive drugs have additional approved indications and effects (e.g., on angina, heart failure, or diabetic kidney disease). These considerations may guide selection of therapy.

These fixed-dose combinations are not indicated for initial therapy (see DOSAGE AND ADMINISTRATION ).

In using ZESTORETIC, consideration should be given to the fact that an angiotensin-converting enzyme inhibitor, captopril, has caused agranulocytosis, particularly in patients with renal impairment or collagen vascular disease, and that available data are insufficient to show that lisinopril does not have a similar risk (see WARNINGS ).

In considering the use of ZESTORETIC, it should be noted that ACE inhibitors have been associated with a higher rate of angioedema in black than in nonblack patients (see WARNINGS, Lisinopril ).

Source: the FDA label for Zestoretic (Almatica Pharma Inc.), March 31, 2025. Full label on DailyMed 

Good to know

  • A regular generic may look different from Zestoretic. The FDA requires it to work the same way.
  • We didn’t find a savings card from Zestoretic’s maker.
  • Don’t stop or change a medicine without talking to your pharmacist or prescriber.